Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;30(7):1005-10.
doi: 10.1038/eye.2016.79. Epub 2016 Apr 22.

The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study

A Ozkaya  1 , Z Alkin  1 , M Ozveren  1 , A T Yazici  1 , M Taskapili  1
Affiliations

The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study

A Ozkaya et al. Eye (Lond). 2016 Jul.

Abstract

PurposeTo evaluate the resolution time and the recurrence rate of acute central serous chorioretinopathy (CSC) after spontaneous resolution and low-fluence photodynamic therapy (PDT).MethodsCase-control study: The CSC patients who were admitted to our clinic for the first time were included. No treatment was given during the first 6 months. Patients were treated with PDT after 6 months from the initial signs of the disease, if they did not show any sign of resolution. The patients who showed a significant decrease in subretinal fluid after month 6 were not scheduled for PDT. The primary outcomes were the resolution time and the recurrence rate after the first episode. Secondary outcome measures were the change in BCVA and CRT during the follow up.ResultsA total of 77 consecutive eyes of 77 patients were included, 41 eyes (53.2%) with spontaneously resolved CSC and 36 eyes (46.8%) with PDT-treated CSC. The initial resolution time was 4.1±3.2 months in spontaneous resolution group, and 8.1±0.8 months in PDT group, respectively (P<0.001). The recurrence rate was 51.2% in spontaneous resolution group, and 25% in PDT group (P=0.01). The change in BCVA from baseline to the last follow-up visit was statistically significant in both groups (P=0.002, P=0.003, respectively). The change in CRT from baseline to the last follow up was also statistically significant in both groups (P=0.002, P=0.003, respectively).ConclusionsThe recurrence rate of acute CSC was lower in PDT-treated patients than the spontaneously resolved patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
BCVA changes in spontaneously resolved group and photodynamic therapy group during follow up.
Figure 2
Figure 2
CRT changes in spontaneously resolved group and photodynamic therapy group during follow up. The baseline value for photodynamic therapy group starts from the time of photodynamic therapy.
See this image and copyright information in PMC

References

    1. Klais CM, Ober MD, Ciardella AP, Yannuzzi LA.Central serous chorioretinopathy. In: Ryan SJ (ed)Retina. Vol 2 Elsevier Mosby: Philadelphia, 2006, pp 1135–1161.
    1. Lehmann M, Wolff B, Vasseur V, Martinet V, Manasseh N, Sahel JA et al. Retinal and choroidal changes observed with ‘En face' enhanced-depth imaging OCT in central serous chorioretinopathy. Br J Ophthalmol 2013; 97: 1181–1186. - PubMed
    1. Prünte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996; 121: 26–34. - PubMed
    1. Hirami Y, Tsujikawa A, Sasahara M, Gotoh N, Tamura H, Otani A et al. Alterations of retinal pigment epithelium in central serous chorioretinopathy. Clin Experiment Ophthalmol 2007; 35: 225–230. - PubMed
    1. Alkin Z, Ozkaya A, Agca A, Yazici AT, Demirok A. Early visual and morphologic changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy. J Ocul Pharmacol Ther 2014; 30: 359–365. - PubMed

MeSH terms